June 22 - 26, 2018
Boston Marriott Copley Place
Boston, Massachusetts, USA
Abstract submission deadline: Friday, April 6
Advance registration deadline: Friday, May 11
June 22-26, 2018Boston Marriott Copley Place
Abstract Submission and Clinical Trials Placeholder Deadline: Friday, April 6, 2018, 11:59 p.m. ET
Award Application Deadline: Friday, April 6, 2018, 11:59 p.m. ETDeadline to Submit Final Placeholder Clinical Trials Data:Friday, May 4, 2018
Advance Registration Deadline: Friday, May 11, 2018
Scientific Committee ChairAri M. Melnick, Weill Cornell Medical College, New York, New York
This must-attend program will provide a unique forum for interactive discussion and brainstorming among basic scientists, translational researchers, clinical investigators, hematologists, radiotherapists, pediatric oncologists, pathologists; and computational and systems biologists, and patient-advocates about how recent advances and emerging areas of lymphoma research hold enormous potential for transforming clinical care.
The lymphoma field is advancing rapidly, thanks to the full sequencing of the lymphoma genome, the discovery of new mechanistic data explaining how mutations work, the development of targeted therapies, recognition of “pre-lymphoma” states as potential risk factors, the advent of immunotherapy, and the unique features of immune tumors. One of the primary goals of this meeting is to generate discussion among clinical and laboratory-based thought leaders in the field by the inclusion of panel discussions in each session. We hope that this novel format will be highly interactive and generate productive ideas to be used as reference points for moving the field forward.
Scientific Committee Cochairs and Scientific Advisory Committee
Continuing Medical Education Activity
AMA PRA Category 1 CreditsTM available.